Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Intervention1: HP-MBMP (Healthy Breast-Mind Body Medicine Program) & Standard care: “Healthy Breast MBM Program ? (60 minutes)per day X 6 Months
A. Annamaya Kosha
1. Diet counselling : Positive prom
Sponsors
CCRYN
Eligibility
Inclusion criteria
Inclusion criteria: Young women aged 15-39 years’ patients diagnosed with histologically confirmed breast carcinoma with newly diagnosed cases with I – III stages. Patients undergoing active treatment for breast carcinoma, including surgery, chemotherapy, radiation therapy, hormone therapy, or a combination of these treatments. Patients with a ECOG score of 60 or above, indicating a reasonable ability to perform daily activities Patients who can provide informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: Patients with severe cognitive impairments or mental health conditions that may hinder their ability to participate in yoga sessions or complete study assessments Patients with physical disabilities or musculoskeletal conditions that may prevent them from safely engaging in yoga practices Patients with severe uncontrolled comorbidities (e.g., heart failure, chronic obstructive pulmonary disease) that may limit their ability to participate in yoga safely Patients currently engaged in other mind-body practices or alternative therapies that may confound the study results Patients with a history of prior yoga intervention for breast carcinoma within the past six months Pregnant patients, as yoga practices may need to be modified during pregnancy, and hormonal changes during pregnancy can impact study outcomes Patients not having access to smartphones and Internet connectivity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep Quality (PSQI)Timepoint: Day 0, Day 30, 3 month, 6 month/termination of trial | — |
Secondary
| Measure | Time frame |
|---|---|
| Salivary CortisolTimepoint: Day 0, 6 month/termination of trial;Salivary DHEATimepoint: Day 0, 6 month/termination of trial;ACTHTimepoint: Day 0, 6 month/termination of trial;CRHTimepoint: Day 0, 6 month/termination of trial;HRVTimepoint: Day 0, 6 month/termination of trial;Level of LymphedemaTimepoint: Day 0, 6 month/termination of trial;Quality of Life (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire version 3.0)Timepoint: Day 0, Day 30, 3 month, 6 month/termination of trial;Anxiety, Stress and DepressionTimepoint: Day 0, Day 30, 3 month, 6 month/termination of trial;Positive and Negative Affect ScheduleTimepoint: Day 0, Day 30, 3 month, 6 month/termination of trial | — |
Countries
India
Contacts
Public ContactDr Vartika Saxena
AIIMS, Rishikesh
Outcome results
None listed